HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tian Sheng Selected Research

Carcinoma (Carcinomatosis)

1/2019Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tian Sheng Research Topics

Disease

1Ulcerative Colitis
03/2024
1Colitis
03/2024
1Poisoning
06/2022
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2019
1Carcinoma (Carcinomatosis)
01/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Necrosis
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Neoplasms (Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

1Purinergic Receptors (Receptors, Purine)IBA
03/2024
1Dextran SulfateIBA
03/2024
1HydrogenIBA
06/2022
1MetalsIBA
06/2022
1Protons (Proton)IBA
06/2022
1N- (6- (2- bromoacetyl)benzo(d)thiazol- 2- yl)acetamideIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019